Hasan Abu, Sasaki Tadahiro, Phadungsombat Juthamas, Koketsu Ritsuko, Rahim Rummana, Ara Nikhat, Biswas Suma Mita, Yonezawa Riku, Nakayama Emi E, Rahman Mizanur, Shioda Tatsuo
Evercare Hospital Dhaka (Ex Apollo Hospitals Dhaka), Dhaka 1229, Bangladesh.
Research Institute of Microbial Diseases, Osaka University, Suita 565-0781, Japan.
Trop Med Infect Dis. 2022 Feb 28;7(3):38. doi: 10.3390/tropicalmed7030038.
Influenza is one of the most common respiratory virus infections. We analyzed hemagglutinin (HA) and neuraminidase (NA) gene segments of viruses isolated from influenza patients who visited Evercare Hospital Dhaka, Bangladesh, in early 2020 immediately before the coronavirus disease 2019 (COVID-19) pandemic. All of them were influenza virus type A (IAV) H1N1pdm. Sequence analysis of the HA segments of the virus strains isolated from the clinical specimens and the subsequent phylogenic analyses of the obtained sequences revealed that all of the H1N1pdm recent subclades 6B.1A5A + 187V/A, 6B.1A5A + 156K, and 6B.1A5A + 156K with K209M were already present in Bangladesh in January 2020. Molecular clock analysis results suggested that the subclade 6B.1A5A + 156K emerged in Denmark, Australia, or the United States in July 2019, while subclades 6B.1A5A + 187V/A and 6B.1A5A + 156K with K209M emerged in East Asia in April and September 2019, respectively. On the other hand, sequence analysis of NA segments showed that the viruses lacked the H275Y mutation that confers oseltamivir resistance. Since the number of influenza cases in Bangladesh is usually small between November and January, these results indicated that the IAV H1N1pdm had spread extremely rapidly without acquiring oseltamivir resistance during a time of active international flow of people before the COVID-19 pandemic.
流感是最常见的呼吸道病毒感染之一。我们分析了2020年初在孟加拉国达卡爱康医院就诊的流感患者所分离病毒的血凝素(HA)和神经氨酸酶(NA)基因片段,当时正值2019冠状病毒病(COVID-19)大流行前夕。所有病毒均为甲型流感病毒(IAV)H1N1pdm。对从临床标本中分离出的病毒株的HA片段进行序列分析,并对所得序列进行系统发育分析,结果显示,所有H1N1pdm近期亚分支6B.1A5A + 187V/A、6B.1A5A + 156K以及带有K209M的6B.1A5A + 156K在2020年1月时已在孟加拉国出现。分子钟分析结果表明,亚分支6B.1A5A + 156K于2019年7月在丹麦、澳大利亚或美国出现,而亚分支6B.1A5A + 187V/A和带有K209M的6B.1A5A + 156K分别于2019年4月和9月在东亚出现。另一方面,NA片段的序列分析显示,这些病毒缺乏赋予对奥司他韦耐药性的H275Y突变。由于孟加拉国11月至1月期间流感病例数通常较少,这些结果表明,在COVID-19大流行之前人员国际流动活跃的时期,IAV H1N1pdm传播极快,且未获得对奥司他韦的耐药性。